HealthStream Inc. Reports Q2 2025 Revenues of $674.4M, Adjusted EBITDA of $517.6M, Surpassing FY 2024 Revenues of $6,291.6M

Reuters
08/12
HealthStream Inc. Reports <a href="https://laohu8.com/S/QTWO">Q2</a> 2025 Revenues of $674.4M, Adjusted EBITDA of $517.6M, Surpassing FY 2024 Revenues of $6,291.6M

HealthStream Inc. has reported its financial results for the second quarter of 2025, revealing revenues of $674.4 million. This represents an increase from the fiscal year 2024 revenues, which stood at $6291.6 million. Additionally, the company's quarterly adjusted EBITDA reached $517.6 million, compared to the fiscal year 2024 adjusted EBITDA of $566.8 million. HealthStream boasts a strong balance sheet with $690.6 million in cash as of the second quarter of 2025 and no debt. The company continues to serve the U.S. healthcare industry with enterprise-level, subscription-based products, generating recurring revenues. HealthStream remains a market leader in workforce solutions for learning, credentialing, and scheduling within healthcare organizations. The company is focused on addressing the industry's challenges in improving patient safety and workforce retention.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. HealthStream Inc. published the original content used to generate this news brief on August 11, 2025, and is solely responsible for the information contained therein.

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10